New!

COVID-19 Antibodies – R&D Samples Available

Published: 17.09.2020

undefinedWe are pleased to let you know that we are developing several monoclonal antibodies specific to SARS-CoV2 nucleoproteins (Cat.# 3CV4) and to Spike RBD (Cat.# 3CV2). The antibodies have been tested with COVID-19 positive patient samples.

See data sheets:
Cat.# 3CV2 Monoclonal anti-SARS-CoV-2 Spike
Cat.# 3CV4 Monoclonal anti-SARS-CoV-2 Nucleoprotein

Limited amounts of R&D samples are available, please inquire below:

See all our COVID-19 Products

undefined

Terms: The sample opportunity is only available to end users. Distributors and re-sellers are not included in this promotion. The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!